查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1540918

2024-2032 年泌尿生殖药物市场报告（按适应症、产品和地区）

Genitourinary Drugs Market Report by Indication, Product, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球泌尿生殖药物市场规模达332亿美元。

泌尿生殖系统包括肾臟、输尿管、膀胱、尿道和生殖器官，在生殖和排除体内废物方面发挥至关重要的作用。先天性异常、医源性损伤、癌症、创伤、感染、肾积水和发炎可能会阻碍其功能。由于患有这些疾病的人数不断增加，全球对泌尿生殖药物的需求不断增加。泌尿生殖药物有助于治疗生殖器官、排泄系统和泌尿道疾病。它们也用于治疗膀胱痉挛和勃起功能障碍以及抑制子宫收缩以防止早产。

泌尿生殖药物市场趋势：

泌尿生殖器官损伤风险的增加是影响市场成长的主要因素之一。此外，由于泌尿生殖药物可有效治疗患有慢性肾衰竭和泌尿道感染的儿科族群，因此其在世界各地的销售量正在增加。除此之外，领先的市场参与者正致力于推动製剂技术，以推出有助于治疗对传统化疗和荷尔蒙治疗药物产生抗药性的慢性前列腺癌患者的药物。此外，多家跨国公司 (MNC) 正在与生物製药领导者合作推出下一代疗法并巩固其在市场中的地位。这与后期临床试验中的管道药物数量大幅增加相结合，正在促进市场成长。除此之外，研发（R＆D）计画资金的增加，以及许多国家的管理和非管理机构赞助的医疗保健基础设施的改善，预计将在未来几年推动泌尿生殖药物的需求。

本报告回答的关键问题

  • 全球泌尿生殖药物市场有多大？ 2024-2032年全球泌尿生殖药物市场的预期成长率是多少？
  • 推动全球泌尿生殖药物市场的关键因素是什么？
  • COVID-19 对全球泌尿生殖药物市场有何影响？
  • 根据适应症，全球泌尿生殖药物市场的细分如何？
  • 基于该产品的全球泌尿生殖药物市场的细分如何？
  • 全球泌尿生殖药物市场的重点区域有哪些？
  • 全球泌尿生殖药物市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球泌尿生殖药物市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依迹象

  • 摄护腺癌
    • 市场趋势
    • 市场预测
  • 卵巢癌
    • 市场趋势
    • 市场预测
  • 膀胱癌
    • 市场趋势
    • 市场预测
  • 子宫颈癌
    • 市场趋势
    • 市场预测
  • 肾癌
    • 市场趋势
    • 市场预测
  • 性功能障碍
    • 市场趋势
    • 市场预测
  • 泌尿道感染
    • 市场趋势
    • 市场预测
  • 尿失禁和膀胱过动症
    • 市场趋势
    • 市场预测
  • 性传染病
    • 市场趋势
    • 市场预测
  • 间质性膀胱炎
    • 市场趋势
    • 市场预测
  • 血尿
    • 市场趋势
    • 市场预测
  • 良性摄护腺增生
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：依产品

  • 泌尿科
    • 市场趋势
    • 市场预测
  • 荷尔蒙疗法
    • 市场趋势
    • 市场预测
  • 妇科
    • 市场趋势
    • 市场预测
  • 抗感染药
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 9 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 10 章：价值链分析

第 11 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 12 章：价格分析

第13章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Allergan plc (AbbVie Inc.)
    • Antares Pharma Inc.
    • AstraZeneca plc
    • Bayer AG
    • Bristol-Myers Squibb Company
    • Genentech Inc. (Roche Holding AG)
    • GlaxoSmithKline plc
    • Merck & Co. Inc.
    • Novartis AG
    • Pfizer Inc.
    • Teva Pharmaceutical Industries Ltd.
Product Code: SR112024A4727

The global genitourinary drugs market size reached US$ 33.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 39.6 Billion by 2032, exhibiting a growth rate (CAGR) of 1.9% during 2024-2032.

The genitourinary system includes kidneys, ureters, bladder, urethra, and genital organs, which play a vital role in reproduction and getting rid of waste products from the body. Its functioning can be hampered on account of congenital abnormalities, iatrogenic injuries, cancer, trauma, infections, hydronephrosis, and inflammation. Due to the rising number of individuals suffering from these diseases, there is a rise in the demand for genitourinary drugs across the globe. Genitourinary drugs help treat the reproductive organs, excretory system, and urinary tract conditions. They are also used in the treatment of bladder spasms and erectile dysfunction and suppressing uterine contractions to prevent preterm labor.

Genitourinary Drugs Market Trends:

The increasing risk of genitourinary organ damage represents one of the major factors influencing the growth of the market. Moreover, as genitourinary drugs are effective in treating the pediatric population with chronic kidney failure and urinary tract infections, their sales are increasing around the world. Apart from this, the leading market players are focusing on advancing formulation techniques to introduce drugs that help treat chronic prostate cancer patients who have developed resistance to conventional chemotherapeutic and hormone therapy agents. Furthermore, several multinational companies (MNCs) are collaborating with biopharmaceutical leaders to launch next-generation therapeutics and strengthen their position in the market. This, in confluence with a considerable rise in the number of pipeline drugs in late-stage clinical trials, is contributing to the market growth. Besides this, the increasing funding for research and development (R&D) projects, along with improvements in the healthcare infrastructure sponsored by governing and non-governing agencies of numerous countries, is anticipated to drive the demand for genitourinary drugs in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global genitourinary drugs market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on indication and product.

Breakup by Indication:

Prostate Cancer

Ovarian Cancer

Bladder Cancer

Cervical Cancer

Renal Cancer

Erectile Dysfunction

Urinary Tract Infections

Urinary Incontinence and Overactive Bladder

Sexually Transmitted Diseases

Interstitial Cystitis

Hematuria

Benign Prostatic Hyperplasia

Breakup by Product:

Urological

Hormonal Therapy

Gynecological

Anti-infectives

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Allergan plc (AbbVie Inc.), Antares Pharma Inc., AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Genentech Inc. (Roche Holding AG), GlaxoSmithKline plc, Merck & Co. Inc., Novartis AG, Pfizer Inc. and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report

  • 1. How big is the global genitourinary drugs market?
  • 2. What is the expected growth rate of the global genitourinary drugs market during 2024-2032?
  • 3. What are the key factors driving the global genitourinary drugs market?
  • 4. What has been the impact of COVID-19 on the global genitourinary drugs market?
  • 5. What is the breakup of the global genitourinary drugs market based on the indication?
  • 6. What is the breakup of the global genitourinary drugs market based on the product?
  • 7. What are the key regions in the global genitourinary drugs market?
  • 8. Who are the key players/companies in the global genitourinary drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Genitourinary Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Indication

  • 6.1 Prostate Cancer
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Ovarian Cancer
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Bladder Cancer
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Cervical Cancer
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Renal Cancer
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Erectile Dysfunction
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Urinary Tract Infections
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Urinary Incontinence and Overactive Bladder
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast
  • 6.9 Sexually Transmitted Diseases
    • 6.9.1 Market Trends
    • 6.9.2 Market Forecast
  • 6.10 Interstitial Cystitis
    • 6.10.1 Market Trends
    • 6.10.2 Market Forecast
  • 6.11 Hematuria
    • 6.11.1 Market Trends
    • 6.11.2 Market Forecast
  • 6.12 Benign Prostatic Hyperplasia
    • 6.12.1 Market Trends
    • 6.12.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Urological
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Hormonal Therapy
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Gynecological
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Anti-infectives
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Allergan plc (AbbVie Inc.)
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 SWOT Analysis
    • 13.3.2 Antares Pharma Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
    • 13.3.3 AstraZeneca plc
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
    • 13.3.4 Bayer AG
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Bristol-Myers Squibb Company
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 Genentech Inc. (Roche Holding AG)
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 SWOT Analysis
    • 13.3.7 GlaxoSmithKline plc
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Merck & Co. Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Novartis AG
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Pfizer Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Teva Pharmaceutical Industries Ltd.
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials

List of Figures

  • Figure 1: Global: Genitourinary Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Genitourinary Drugs Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Genitourinary Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Genitourinary Drugs Market: Breakup by Indication (in %), 2023
  • Figure 5: Global: Genitourinary Drugs Market: Breakup by Product (in %), 2023
  • Figure 6: Global: Genitourinary Drugs Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Genitourinary Drugs (Prostate Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 8: Global: Genitourinary Drugs (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 9: Global: Genitourinary Drugs (Ovarian Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Genitourinary Drugs (Ovarian Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Genitourinary Drugs (Bladder Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Genitourinary Drugs (Bladder Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Genitourinary Drugs (Cervical Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Genitourinary Drugs (Cervical Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Genitourinary Drugs (Renal Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Genitourinary Drugs (Renal Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Genitourinary Drugs (Erectile Dysfunction) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Genitourinary Drugs (Erectile Dysfunction) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Genitourinary Drugs (Urinary Tract Infections) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Genitourinary Drugs (Urinary Tract Infections) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Genitourinary Drugs (Urinary Incontinence and Overactive Bladder) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Genitourinary Drugs (Urinary Incontinence and Overactive Bladder) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Genitourinary Drugs (Sexually Transmitted Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Genitourinary Drugs (Sexually Transmitted Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Genitourinary Drugs (Interstitial Cystitis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Genitourinary Drugs (Interstitial Cystitis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Genitourinary Drugs (Hematuria) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Genitourinary Drugs (Hematuria) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Genitourinary Drugs (Benign Prostatic Hyperplasia) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Genitourinary Drugs (Benign Prostatic Hyperplasia) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Genitourinary Drugs (Urological) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Genitourinary Drugs (Urological) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Genitourinary Drugs (Hormonal Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Genitourinary Drugs (Hormonal Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Genitourinary Drugs (Gynecological) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Genitourinary Drugs (Gynecological) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Genitourinary Drugs (Anti-infectives) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Genitourinary Drugs (Anti-infectives) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Genitourinary Drugs (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Genitourinary Drugs (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: North America: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: North America: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: United States: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: United States: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Canada: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Canada: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Asia-Pacific: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Asia-Pacific: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: China: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: China: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Japan: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Japan: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: India: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: India: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: South Korea: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: South Korea: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Australia: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Australia: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Indonesia: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Indonesia: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Others: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Others: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Europe: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Europe: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Germany: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Germany: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: France: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: France: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: United Kingdom: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: United Kingdom: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Italy: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Italy: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Spain: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Spain: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Russia: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Russia: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Others: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Others: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Latin America: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Latin America: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Brazil: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Brazil: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Mexico: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Mexico: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Others: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Others: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Middle East and Africa: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Middle East and Africa: Genitourinary Drugs Market: Breakup by Country (in %), 2023
  • Figure 89: Middle East and Africa: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 90: Global: Genitourinary Drugs Industry: SWOT Analysis
  • Figure 91: Global: Genitourinary Drugs Industry: Value Chain Analysis
  • Figure 92: Global: Genitourinary Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Genitourinary Drugs Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Genitourinary Drugs Market Forecast: Breakup by Indication (in Million US$), 2024-2032
  • Table 3: Global: Genitourinary Drugs Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 4: Global: Genitourinary Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Genitourinary Drugs Market: Competitive Structure
  • Table 6: Global: Genitourinary Drugs Market: Key Players